Canada authorises use of Pfizer/BioNTech anti-Covid vaccine booster
Oct 08, 2022, at 08:32 pm
Ottawa/IBNS: Health Canada Friday authorised the use of a Pfizer/BioNTech COVID-19 vaccine booster targeting Omicron sub variants.
Canada adds another weapon against Covid19
Oct 08, 2022, at 05:11 pm
Ottawa/IBNS: Health Canada Friday authorized the use of a Pfizer/BioNTech COVID-19 vaccine booster targeting Omicron sub variants.
Moderna sues Pfizer, BioNTech alleging patent infringement over Covid vaccine
Aug 27, 2022, at 02:38 am
Washington/IBNS: Moderna Friday announced to sue its suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their Covid-19 shot, which was administered to hundreds of millions around the world.
Pfizer CEO Albert Bourla tests positive for Covid-19
Aug 16, 2022, at 02:36 am
Washington/UNI: Pfizer CEO Albert Bourla said on Monday that he had tested positive for COVID-19 despite having received four doses of the Pfizer-BioNTech vaccine against the novel coronavirus.
WHO recommends COVID-19 drug and urges transparency around pricing
Apr 22, 2022, at 11:28 pm
New York: A highly successful COVID-19 therapy must be made available to more people, the World Health Organization (WHO) has said, calling for wider distribution and greater transparency surrounding its pricing.
Jan 26, 2022, at 09:20 pm
New York: Pfizer Inc and BioNTech SE on Wednesday announced the initiation of a clinical study to evaluate the safety, tolerability and immunogenicity of an Omicron-based vaccine candidate in healthy adults 18 through 55 years of age.
Delhi: Most Omicron patients got Pfizer vaccine, says expert
Dec 24, 2021, at 11:25 pm
New Delhi/UNI: A majority of Omicron patients admitted to different hospitals of the national capital have been vaccinated by Pfizer-BioNTech while a few among them had even taken its booster jabs, informed sources said.
US drug regulator approves Pfizer's Covid pill for people aged 12 and above
Dec 23, 2021, at 05:32 am
Washington/IBNS: The US Food and Drug Administration (FDA) on Wednesday authorized Pfizer's Covid pill for high-risk people aged 12 and over.
Study shows Pfizer, AstraZeneca COVID-19 vaccines less effective against Omicron strain: WHO
Dec 19, 2021, at 02:13 am
Geneva/UNI/Sputnik: Preliminary results of a non-peer-reviewed study from the United Kingdom indicate reduced effectiveness of the Pfizer and AstraZeneca vaccines against the Omicron coronavirus variant, the World Health Organization (WHO) has said.
Three doses of Pfizer Covid 19 vaccine will neutralize Omicron strain, says developer
Dec 09, 2021, at 12:45 am
New York: Pfizer Inc.and BioNTech SE on Wednesday announced results from an initial laboratory study demonstrating that serum antibodies induced by the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) neutralize the SARS-CoV-2 Omicron variant after three doses.
Pfizer seeks emergency use authorization for COVID-19 oral antiviral candidate
Nov 17, 2021, at 02:45 pm
Washington: Pfizer Inc. on Tuesday announced it is seeking Emergency Use Authorization (EUA) of its investigational oral antiviral candidate, PAXLOVID, for the treatment of mild to moderate COVID-19 in patients at increased risk of hospitalizations or death.
Pfizer to allow other drug manufacturers to make its Covid pill, 95 nations to benefit
Nov 17, 2021, at 02:21 am
Geneva/IBNS: US pharmaceutical major Pfizer has announced plans to make its antiviral pill against COVID-19 available to other drug manufacturers so as to benefit the world's least wealthy countries.
Pfizer says its antiviral pill 89 pc effective in preventing severe Covid
Nov 06, 2021, at 06:12 am
Pfizer has stopped the clinical trial for experimental antiviral pill for COVID-19 before the stipulated period after the drug was shown to reduce by 89 percent the chances of hospitalization or death for adults at risk of developing severe symptoms, the company said.
Pfizer COVID-19 antiviral pill shows it cuts risks of hospitalization, death by 89 percent
Nov 05, 2021, at 11:30 pm
Pharmaceutical giant Pfizer Inc on Friday announced its investigational novel COVID-19 oral antiviral candidate,PAXLOVID, significantly reduced hospitalization and death, based on an interim analysis of the Phase 2/3 EPIC-HR (Evaluation of Protease Inhibition for COVID-19 in High-Risk Patients) randomized, double-blind study of non-hospitalized adult patients with COVID-19, who are at high risk of progressing to severe illness.
Benefits of Pfizer Covid-19 vaccine for children surpass risks: US Drug Regulator
Oct 23, 2021, at 11:22 pm
Washington/UNI/Sputnik: The benefits expected from the Pfizer Covid-19 vaccine shots for children between 5 and 11 years old outweigh the risks of side effects, the US Food and Drug Administration (FDA) said in a report.
Oct 05, 2021, at 02:51 pm
New York: Two doses of Pfizer-BioNTech (BNT162b2) are 90% effective against COVID-19 hospitalizations for all variants, including delta, for at least six months, confirms a new study from Kaiser Permanente and Pfizer published in The Lancet.
India won't buy 'expensive' Moderna, Pfizer Covid-19 shots as local production soars: Report
Sep 22, 2021, at 03:40 am
New Delhi/IBNS: India would not buy Covid-19 vaccines from foreign producers Pfizer/BioNTech and Moderna as domestic production of the shots has increased manifold, Reuters reported citing sources.
Clinical trial results show Pfizer COVID-19 vaccine is safe for children aged between 5 to 11
Sep 20, 2021, at 10:28 pm
New York: Pfizer Inc and BioNTech SE on Monday announced results from a Phase 2/3 trial showing a favorable safety profile and robust neutralizing antibody responses in children 5 to 11 years of age using a two-dose regimen of 10 µg administered 21 days apart, a smaller dose than the 30 µg dose used for people 12 and older.
Aug 04, 2021, at 01:47 am
New Delhi/IBNS: All US-based Covid-19 vaccine makers are insisting on protection from lawsuits and liability and India is reluctant to allow their entry on these conditions, delaying their availability in India, according to NK Arora, head of the government's vaccine panel.
Vaccine antibody levels start to wane at around 2-3 months: Study
Jul 27, 2021, at 09:22 pm
London: Total antibody levels appear to start declining from as early as six weeks after complete vaccination and can reduce by more than 50% over 10 weeks, according to new data from UCL’s Virus Watch study.
Pfizer claims its Covid19 vaccine 'very effective' against Delta variant
Jun 25, 2021, at 06:35 am
New Delhi/IBNS: US pharma giant Pfizer, which is in the final stages of closing a coronavirus vaccine deal with the Indian government, has said its jab is very effective against the Delta variant of the virus, according to media reports.
CEO says Pfizer vaccine is effective against all existing COVID-19 variants
Jun 11, 2021, at 02:23 pm
Washington/Sputnik: No COVID-19 variant has escaped the protection of Pfizer's vaccine, but the company continues to monitor and test it against emerging strains around the world, CEO Albert Bourla said on Thursday.
Pfizer to start testing COVID-19 vaccine in large group of children aged below 12
Jun 09, 2021, at 03:43 pm
Pfizer on Tuesday said it will begin testing its COVID-19 vaccine on a larger group of children under the age of 12.
Gap between two Covid vaccine doses should be reduced to combat Delta variant: Lancet study
Jun 05, 2021, at 02:30 am
New Delhi/IBNS: Amid the spread of the Delta variant of coronavirus, which is dominant in India, the gap between the two doses should be reduced and boosters must be provided to those whose immunity may not be high enough, The Lancet journal said in a new study.
'Well established' foreign COVID-19 vaccines makers need no bridging clinical trials in India
Jun 02, 2021, at 06:38 pm
New Delhi/IBNS: The Indian government has exempted "well established" foreign COVID-19 vaccines makers from any bridging clinical trials if it has been certified by the National Control Lab of the country where it is made, media reports said.
Pfizer's COVID vaccine approved for minors aged 12-15 in Japan
Jun 01, 2021, at 01:49 pm
Moscow/Sputnik: The Japanese government approved Pfizer's COVID-19 vaccine for ages 12 to 15 on Monday, the media reported.
May 23, 2021, at 06:53 am
London/IBNS: Two doses of AstraZeneca vaccine or Pfizer vaccine can give more than 80 per cent protection from the B1.617.2 variant of coronavirus first found in India, a new study conducted by the UK government has revealed, media reports said.
US regulator to authorize Pfizer-BioNTech vaccine for 12-15 year olds next week: Reports
May 04, 2021, at 06:19 pm
Washinton/Sputnik: The US Food and Drug Administration (FDA) is preparing to approve the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15, The New York Times reported, citing federal officials.
Pfizer in talks with India on vaccine approval; company pledges $70M in medicine donations
May 04, 2021, at 05:59 pm
Pfizer is discussing with the Indian government expedited approval of its vaccine, company CEO Alber Bourla has said while announcing a donation of medicines worth $70 million to fight the resurgent pandemic.
Pfizer could have first oral drug for COVID-19 by end of year: CEO Bourla
Apr 29, 2021, at 12:03 am
Washington/Sputnik: Pfizer’s experimental oral drug to treat COVID-19 at the first sign of illness could be available before the end of the year, Chief Executive Albert Bourla told CNBC on Tuesday.